Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Scientific Corp (NYSE:BSX)

16.07
Delayed Data
As of Feb 08
 -0.55 / -3.31%
Today’s Change
14.18
Today|||52-Week Range
19.06
-12.85%
Year-to-Date

Today’s Trading

Previous close16.62
Today’s open16.45
Day’s range15.67 - 16.51
Volume16,522,505
Average volume (3 months)10,201,359
Market cap$22.4B
Dividend yield--
Data as of 02/08/2016

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)+8.71%
Earnings growth (next 5 years)+10.78%
Revenue growth (last year)+2.31%
P/E ratioNM
Price/Sales2.40
Price/Book3.42

Competitors

 Today’s
change
Today’s
% change
ZBHZimmer Biomet Holdin...-2.98-3.14%
EWEdwards Lifesciences...-5.05-6.16%
BDXBecton Dickinson and...-2.37-1.75%
BCRC R Bard Inc-3.26-1.78%
Data as of 02/08/2016

Financials

Next reporting dateApril 26, 2016
EPS forecast (this quarter)$0.24
Annual revenue (last year)$7.3B
Annual profit (last year)-$119.0M
Net profit margin-1.63%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Michael F. Mahoney
Executive Vice President-
Operations
Edward Mackey
Corporate headquarters
Marlborough, Massachusetts

Forecasts

Partner Offers